Posted on 13/07/2010 in Animal Health Supplier News Animalcare has forecast a 15 per cent year-on-year increase in its company revenue in the 12 months ending June 30th 2010.
The veterinary medicines firm has published its pre-close trading statement ahead of the publication of its preliminary results later this year, stating that its earnings performance are tracking ahead of market expectations.
This strong performance was driven in large part by its veterinary supplies unit, thanks to the introduction of successful new products such as the flavoured variant of its generic heart drug Benazecare.
In addition, two more products were launched later in the year to boost revenues further, while Animalcare's board expects that more new offerings will be brought to market in the near future.
Animalcare will confirm these figures when its full preliminary financial report for the year is published on October 4th.
Earlier this year, Animalcare appointed Stephen Wildridge as its new chief executive, replacing Simon Riddell, as the company moves towards an increased focus on veterinary pharmaceuticals.Other news stories from 13/07/2010
Read more in the Zenopa News Archive
How this news is generated
|
